Biotechnology is the application of technology and science to develop solutions for societal issues like climate change mitigation as well as the accessibility and sustainable natural resources and food security. Biotechnology companies are classified into different categories in relation to the solutions they seek to provide.
The majority of biotech companies are pharmaceutical companies which produce medicines for humans and animals. Typically, the process of developing drugs takes years and is a very risky venture with a high percentage of drugs that are developed failing to get from the lab in the research lab to the shelves of the pharmacy.
However, biotech isn’t restricted to the development of pharmaceuticals; a wide range of other industries can benefit from the technology. This includes cosmetics, agriculture and food technology. Industrial biotechnology, nutraceuticals and veterinary products are included.
Other areas of research include mRNA vaccines, which were used in the COVID-19 Pandemic and monoclonal antibody, which are currently being tested for HIV treatment. The industry is characterised by high operating costs and requires substantial funds for R&D.
Many biotech companies do not succeed in the beginning stages. Those who are profitable have strong pipelines, and they can generate non-organic revenues. Biotech investing can be rewarding, but you must also consider the risks. For example, it is not uncommon for a biotech stock to experience an explosive run when it is announced that one of its innovative treatments has been successful, and these spikes can be difficult for investors with small budgets to endure.